Houston Methodist DeBakey Heart and Vascular Center
Avatar

Changing Landscape of Heart Failure Care: Should ARNI and SGLT2 Inhibitors Be Used in HF(pEF) Patients?

By Houston Methodist DeBakey Heart and Vascular Center FEATURING Clyde Yancy
By Houston Methodist DeBakey Heart and Vascular Center FEATURING Clyde Yancy
363 views
March 24, 2021
Comments 0
Login to view comments. Click here to Login

Featured Video

03:26
Boehringer Ingelheim and Lilly Cardiology

Optimal Medical Therapy for Patients with HFrEF - Four Pharmacologic…

Feat. N. Singh, N. Lepor, K. Watson, M. Budoff, R. Chilton

Featured Video

11
Boehringer Ingelheim

Timely Implementation of HFrEF GDMT

Feat. N. Singh

Related Videos

11:37

ACC 2022: An Embarrassment of Riches - Updated Guideline Recommendat…

ACC 2022 Conference Coverage

P. Heidenreich

23.0K views
11:25

ACC 2023: SGLT2i Use - Dos and Don'ts

ACC 2023 Conference Coverage

A. Armbruster

22.0K views
27:14

Which Diuretic(s) Are Best in HF? Update Based on Recent Clinical Tr…

MUSC Cardiology

R. Mentz

14.6K views
09:52

AHA 2022: Torsemide Comparison With Furosemide for Management of Hea…

AHA 2022 Conference Coverage

R. Mentz

7.6K views
13:07

2021 ADA Highlights: Heart Failure With Reduced Ejection Fraction - …

Michelle Kittleson

6.4K views
61:49

Management of Heart Failure

Obafemi Awolowo University

O. A. Akinyele

574 views
11:29

Esmolol in Refractory VF

The 9th Annual Western New England Acute Cardiology Conference

B. Hoffman

69 views
21:49

Benefits of Slowing the Heart with Ivabradine

San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians

33 views
35:16

HFpEF or Amyloidosis? The Right Therapies for Right Patients

Scripps Health

M. Kittleson

5.4K views
15:47

HFpEF in Women

Scripps Health

B. Borlaug

77 views
17:29

Cardiac Amyloidosis: A New Era of Diagnostics and Therapeutics

UCLA Health

D. Vucicevic

251 views
19:30

Hot Topics in Heart Failure ACC.22

ACC 2022 Conference Coverage

N. Ibrahim

3.5K views
28:48

Weight Loss as Treatment for HFpEF: An Update on Drugs and Procedures

MUSC Cardiology

S. Litwin

271 views
21:02

Cardiotoxicity: Anthracyclines

Scripps Health

M. Davis

45 views
22:35

ACC 2024 Insights: Stop the Meds! Treat the Comorbidities for Optima…

ACC 2024 Insights

K. Williams

3.2K views
20:59

Digoxin Update 2023: Are the Current Digoxin Monitoring Guidelines H…

Mary E. Money

3.2K views
15:51

SGLT2 Inhibition in 2024: Use in Heart Failure and Mechanism of Acti…

28th Annual Heart Failure 2024: An Update on Therapy

M. Packer

141 views
16:30

The Valve Trials Are Done: Interventional HFpEF Is the Next Big Thing

Northwestern Medicine Bluhm Cardiovascular Institute

S. Shah

47 views
28:46

Heart Failure Case Presentations

San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians

B. Greenberg, G. Fonarow, N. Wettersten, M. Rosa Costanzo

96 views
34:18

Cancer Survivorship: How To Monitor for Cardiac Disease Following Tr…

Scripps Health

A. Kuo

196 views
AUTOPLAY